Position in AGEN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$39,550
-$68,418 QoQ
Shares Held
12,925
-62.4% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 103 holders
Holding Since
Sep 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Virtu Financial LLC holds $37,870,510 across 148 Biotechnology names. AGEN ranks #93 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
58,459 | $4,130,128 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
29,790 | $3,954,026 | |
| 3 | ABVX |
Abivax S.A.
|
19,155 | $2,552,595 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
9,220 | $2,256,779 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
12,556 | $1,439,796 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
8,163 | $1,000,620 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
17,524 | $962,768 | |
| 8 | IOVA |
Iovance Biotherapeutics, Inc.
|
221,500 | $921,440 |
All Filings in AGEN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,550 | 12,925 | Shares | Defined | 2026-08-13 | |
| 2025-12-31 | $107,968 | 34,385 | Shares | Defined | 2026-02-23 | |
| 2024-12-31 | $51,377 | 18,751 | Shares | Defined | 2025-02-11 | |
| 2023-12-31 | $213,672 | 257,437 | Shares | Defined | 2024-02-26 | |
| 2022-09-30 | $156,851 | 76,513 | Shares | Defined | 2022-11-07 | |
| 2021-09-30 | $108,627 | 20,691 | Shares | Defined | 2021-11-12 | |
| 2020-12-31 | $174,540 | 54,887 | Shares | Defined | 2021-02-24 | |
| 2020-09-30 | $225,231 | 56,308 | Shares | Defined | 2020-12-11 | |
| No filing history on record for this holder in this stock. | ||||||